These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 21450501)

  • 21. Improvement in insulin sensitivity without concomitant changes in body composition and cardiovascular risk markers following fixed administration of a very low growth hormone (GH) dose in adults with severe GH deficiency.
    Yuen KC; Frystyk J; White DK; Twickler TB; Koppeschaar HP; Harris PE; Fryklund L; Murgatroyd PR; Dunger DB
    Clin Endocrinol (Oxf); 2005 Oct; 63(4):428-36. PubMed ID: 16181235
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extracellular matrix metalloproteinase inducer stimulates tumor angiogenesis by elevating vascular endothelial cell growth factor and matrix metalloproteinases.
    Tang Y; Nakada MT; Kesavan P; McCabe F; Millar H; Rafferty P; Bugelski P; Yan L
    Cancer Res; 2005 Apr; 65(8):3193-9. PubMed ID: 15833850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New insights into molecular mechanisms of diffuse coronary ectasiae: a possible role for VEGF.
    Savino M; Parisi Q; Biondi-Zoccai GG; Pristipino C; Cianflone D; Crea F
    Int J Cardiol; 2006 Jan; 106(3):307-12. PubMed ID: 16337037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Night sleep EEG and daytime sleep propensity in adult hypopituitary patients with growth hormone deficiency before and after six months of growth hormone replacement.
    Schneider HJ; Oertel H; Murck H; Pollmächer T; Stalla GK; Steiger A
    Psychoneuroendocrinology; 2005 Jan; 30(1):29-37. PubMed ID: 15358440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated serum levels of vascular endothelial growth factor in patients with preeclampsia.
    Baker PN; Krasnow J; Roberts JM; Yeo KT
    Obstet Gynecol; 1995 Nov; 86(5):815-21. PubMed ID: 7566855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Usefulness of VEGF, MMP-2, MMP-3 and TIMP-2 serum level evaluation in patients with adrenal tumours.
    Kolomecki K; Stepien H; Bartos M; Kuzdak K
    Endocr Regul; 2001 Mar; 35(1):9-16. PubMed ID: 11308991
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin sensitivity in growth hormone (GH)-deficient adults and effect of GH replacement therapy.
    Alford FP; Hew FL; Christopher MC; Rantzau C
    J Endocrinol Invest; 1999; 22(5 Suppl):28-32. PubMed ID: 10442567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of biologic surrogate markers from a Children's Oncology Group Phase I trial of gefitinib in pediatric patients with solid tumors.
    Jimeno A; Daw NC; Amador ML; Cusatis G; Kulesza P; Krailo M; Ingle AM; Blaney SM; Adamson P; Hidalgo M;
    Pediatr Blood Cancer; 2007 Sep; 49(3):352-7. PubMed ID: 16425266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum and plasma vascular endothelial growth factor levels in testicular cancer patients.
    Ferrero S
    Ann Oncol; 2004 Jun; 15(6):989-90. PubMed ID: 15151961
    [No Abstract]   [Full Text] [Related]  

  • 30. Growth hormone increases regulator of calcineurin 1-4 (Rcan1-4) mRNA through c-JUN in rat liver.
    Nakata T; Toyoshima Y; Yagi T; Katsumata H; Tokita R; Minami S
    PLoS One; 2020; 15(6):e0235270. PubMed ID: 32589657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Serum levels of matrix metaloproteinase 2 (MMP-2), matrix metaloproteinase 9 (MMP-9) and tissue inhibitor of metaloproteinase 2 (TIMP-2) in children and adolescents with growth hormone deficiency].
    Szczepańska-Kostro J; Kowalewski M; Urban M; Gardziejczyk M
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(4):257-60. PubMed ID: 17239302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum levels of insulin-like growth factor binding proteins (IGFBP)-4 and -5 correlate with bone mineral density in growth hormone (GH)-deficient adults and increase with GH replacement therapy.
    Thorén M; Hilding A; Brismar T; Magnusson P; Degerblad M; Larsson L; Sääf M; Baylink DJ; Mohan S
    J Bone Miner Res; 1998 May; 13(5):891-9. PubMed ID: 9610754
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Growth hormone deficiency, its influence on bone mineral density and risk of osteoporotic fractures].
    Kuzma M; Payer J
    Cas Lek Cesk; 2010; 149(5):211-6. PubMed ID: 20629339
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum vascular endothelial growth factor (VEGF) is elevated in GH deficient adults.
    Murray RD; Randeva HS; Lewandowski KC; Komorowski J; Lawrance JA; Adams JE; Shalet SM
    Growth Horm IGF Res; 2011 Apr; 21(2):96-101. PubMed ID: 21450501
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth hormone replacement decreases plasma levels of matrix metalloproteinases (2 and 9) and vascular endothelial growth factor in growth hormone-deficient individuals.
    Randeva HS; Lewandowski KC; Komorowski J; Murray RD; O'Callaghan CJ; Hillhouse EW; Stepien H; Shalet SM
    Circulation; 2004 May; 109(20):2405-10. PubMed ID: 15123527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of serum vascular endothelial growth factor (VEGF) and plasma activity of matrix metalloproteinase (MMP) 2 and 9 in lymphoma-affected dogs.
    Gentilini F; Calzolari C; Turba ME; Agnoli C; Fava D; Forni M; Bergamini PF
    Leuk Res; 2005 Nov; 29(11):1263-9. PubMed ID: 15893373
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.